Literature DB >> 21168388

Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells.

Clare Ulyatt1, John Walker, Sreenivasan Ponnambalam.   

Abstract

The role of hypoxia on endothelial cell function and response to growth factors is unknown. Here, we tested the hypothesis that hypoxia re-programs endothelial function by modulating vascular endothelial growth factor receptor levels which in turn alter intracellular signaling and cell function. Hypoxia stimulated VEGF-A and VEGFR1 expression but decreased VEGFR2 levels in endothelial cells. During hypoxia, plasma membrane VEGFR1 levels were elevated whereas VEGFR2 levels were depleted. One functional consequence of hypoxia is a reduction in VEGF-A-stimulated and VEGFR2-regulated intracellular signaling including lowered endothelial nitric oxide synthase activation. Venous, arterial and capillary endothelial cells subjected to hypoxia all exhibited reduced cell migration in response to VEGF-A. A mechanistic explanation is that VEGFR1:VEGFR2 ratio is substantially increased during hypoxia to block VEGF-A-stimulated and VEGFR2-regulated endothelial responses to maximize cell viability and recovery.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168388     DOI: 10.1016/j.bbrc.2010.12.057

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae.

Authors:  Akriti S Sahay; Anjali T Jadhav; Deepali P Sundrani; Girija N Wagh; Savita S Mehendale; Preeti Chavan-Gautam; Sadhana R Joshi
Journal:  Mol Cell Biochem       Date:  2017-08-02       Impact factor: 3.396

2.  Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.

Authors:  Peter Baumgarten; Anna-Eva Blank; Kea Franz; Elke Hattingen; Maika Dunst; Pia Zeiner; Katharina Hoffmann; Oliver Bähr; Lisa Mäder; Benjamin Goeppert; Marcia Machein; Volker Seifert; Joachim P Steinbach; Karl H Plate; Patrick N Harter; Michel Mittelbronn
Journal:  Neuro Oncol       Date:  2015-11-30       Impact factor: 12.300

3.  Gamma-secretase inhibitor DAPT suppresses glioblastoma growth via uncoupling of tumor vessel density from vessel function.

Authors:  Yuhui Zou; Yiqun Cao; Zhijian Yue; Jianmin Liu
Journal:  Clin Exp Med       Date:  2012-07-27       Impact factor: 3.984

4.  Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34+ cells.

Authors:  Shrinidh Joshi; Hannah Wollenzien; Estelle Leclerc; Yagna Pr Jarajapu
Journal:  J Cell Physiol       Date:  2019-04-15       Impact factor: 6.384

Review 5.  Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease.

Authors:  Gina A Smith; Gareth W Fearnley; Michael A Harrison; Darren C Tomlinson; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  J Inherit Metab Dis       Date:  2015-04-14       Impact factor: 4.982

6.  VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis.

Authors:  Nicky D'Haene; Sébastien Sauvage; Calliope Maris; Ivan Adanja; Marie Le Mercier; Christine Decaestecker; Linda Baum; Isabelle Salmon
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

7.  Immunohistochemical biomarkers in gastric cancer research and management.

Authors:  Elena Lastraioli; Maria Raffaella Romoli; Annarosa Arcangeli
Journal:  Int J Surg Oncol       Date:  2012-06-24

8.  Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms.

Authors:  Yagna P R Jarajapu; Sugata Hazra; Mark Segal; Sergio Li Calzi; Sergio LiCalzi; Chandra Jadhao; Chandra Jhadao; Kevin Qian; Sayak K Mitter; Mohan K Raizada; Michael E Boulton; Maria B Grant
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

9.  Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition.

Authors:  Shanmugarajan Krishnan; Emese Szabo; Isabel Burghardt; Karl Frei; Ghazaleh Tabatabai; Michael Weller
Journal:  Oncotarget       Date:  2015-09-08

10.  Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta.

Authors:  Ori Nevo; Dennis K Lee; Isabella Caniggia
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.